Martin H.. Huber Jr's Net Worth
$2.61 Million
Who is Martin H.. Huber Jr?
Martin H.. Huber Jr has an estimated net worth of $2.61 Million. This is based on reported shares across multiple companies, which include Mersana Therapeutics, Inc., Syndax Pharmaceuticals Inc, Xilio Therapeutics, Inc., and TESARO, Inc..
SEC CIK
Martin H.. Huber Jr's CIK is 0001653276
Past Insider Trading and Trends
2023 was Martin H.. Huber Jr's most active year for acquiring shares with 10 total transactions. Martin H.. Huber Jr's most active month to acquire stocks was the month of February. 2017 was Martin H.. Huber Jr's most active year for disposing of shares, totalling 9 transactions. Martin H.. Huber Jr's most active month to dispose stocks was the month of December. 2021 saw Martin H.. Huber Jr paying a total of $677,600.00 for 219,598 shares, this is the most they've acquired in one year. In 2019 Martin H.. Huber Jr cashed out on 210,104 shares for a total of $915,450.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Mersana Therapeutics, Inc. (MRSN) Snapshot price: $1.35
President, CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 116.33K |
$1.76 | -$88,744.48 | 116.33K |
Scheduled
|
Sep 11 - Sep 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 3
| |||
Form 4
|
∞
| 14.47K |
—
|
—
| 14.47K |
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Syndax Pharmaceuticals Inc (SNDX) Snapshot price: $19.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +53.13% | 17K |
—
|
—
| 49K |
Feb 7
| |||
Form 4
| +100.00% | 16K |
—
|
—
| 32K |
Feb 2
| |||
Form 4
|
∞
| 16K |
—
|
—
| 16K |
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.844
PRESIDENT AND HEAD OF R&D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TESARO, Inc. No price found
SVP & Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -12.21K |
$75.00 | -$915,450.00 |
0
|
Jan 22
| |||
Form 4
| +7.76% | 879 |
$37.63 | -$13,960.73 | 12.21K |
Scheduled
|
Sep 21 - Sep 24
| ||
Form 4
| +55.76% | 4.05K |
$54.86 | -$98,912.58 | 11.33K |
Scheduled
|
Mar 1 - Mar 2
| ||
Form 4
| +14.50% | 921 |
$85.24 | -$70,663.96 | 7.27K |
Dec 1 - Dec 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 16
| |||
Form 4
| +11.56% | 658 |
$118.60 | -$70,211.20 | 6.35K |
Scheduled
|
Sep 21 - Sep 22
| ||
Form 4
| +19.30% | 921 |
$153.02 | -$126,853.58 | 5.69K |
Apr 1 - Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 27
| |||
Form 4
| +161.48% | 2.95K |
$177.61 | -$253,627.08 | 4.77K |
Scheduled
|
Mar 1 - Mar 2
| ||
Form 4
|
∞
| 310 |
$136.26 | -$25,889.40 | 13.39 |
Jan 1 - Jan 3
| |||
Form 4
| +79.93% | 673 |
$121.29 | -$39,661.83 | 1.51K |
Nov 1 - Nov 2
| |||
Form 4
|
∞
| 842 |
$108.12 | -$44,112.96 | 842 |
Scheduled
|
Sep 21 - Sep 22
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||